These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19222307)

  • 1. Beta-catenin mutation does not seem to have an effect on the tumorigenesis of pediatric rhabdomyosarcomas.
    Bouron-Dal Soglio D; Rougemont AL; Absi R; Giroux LM; Sanchez R; Barrette S; Fournet JC
    Pediatr Dev Pathol; 2009; 12(5):371-3. PubMed ID: 19222307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.
    Corao DA; Biegel JA; Coffin CM; Barr FG; Wainwright LM; Ernst LM; Choi JK; Zhang PJ; Pawel BR
    Pediatr Dev Pathol; 2009; 12(4):275-83. PubMed ID: 18788887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed embryonal/alveolar rhabdomyosarcoma of the prostate: report of a case with molecular genetic studies and literature review.
    Treetipsatit J; Kittikowit W; Zielenska M; Chaipipat M; Thorner PS; Shuangshoti S
    Pediatr Dev Pathol; 2009; 12(5):383-9. PubMed ID: 19175284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.
    Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D
    Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.
    Fattet S; Haberler C; Legoix P; Varlet P; Lellouch-Tubiana A; Lair S; Manie E; Raquin MA; Bours D; Carpentier S; Barillot E; Grill J; Doz F; Puget S; Janoueix-Lerosey I; Delattre O
    J Pathol; 2009 May; 218(1):86-94. PubMed ID: 19197950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
    Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
    Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
    Ohali A; Avigad S; Naumov I; Goshen Y; Ash S; Yaniv I
    Genes Chromosomes Cancer; 2008 Nov; 47(11):965-70. PubMed ID: 18663749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.
    Annavarapu SR; Cialfi S; Dominici C; Kokai GK; Uccini S; Ceccarelli S; McDowell HP; Helliwell TR
    Lab Invest; 2013 Oct; 93(10):1090-9. PubMed ID: 23999248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors.
    Goldstein M; Meller I; Issakov J; Orr-Urtreger A
    Neoplasia; 2006 May; 8(5):332-43. PubMed ID: 16790082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior.
    Staibano S; Franco R; Tranfa F; Mezza E; Lo Muzio L; Strianese D; Errico ME; Bufo P; Ferrara G; Somma P; Mansueto G; Greco I; Fiorillo A; Bonavolontà G; De Rosa G
    Anticancer Res; 2004; 24(1):249-57. PubMed ID: 15015604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: its correlation with histologic features.
    Hachitanda Y; Toyoshima S; Akazawa K; Tsuneyoshi M
    Mod Pathol; 1998 Dec; 11(12):1222-7. PubMed ID: 9872655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evidence of genetic alterations in chromosome 11 in embryonal and alveolar rhabdomyosarcoma].
    Brinkschmidt C; Poremba C; Schäfer KL; Simon R; Jürgens H; Böcker W; Dockhorn-Dworniczak B
    Verh Dtsch Ges Pathol; 1998; 82():210-4. PubMed ID: 10095436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of invasion promoting genes in childhood rhabdomyosarcoma.
    Armeanu-Ebinger S; Bonin M; Häbig K; Poremba C; Koscielniak E; Godzinski J; Warmann SW; Fuchs J; Seitz G
    Int J Oncol; 2011 Apr; 38(4):993-1000. PubMed ID: 21271214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy.
    Diniz G; Aktas S; Ortac R; Tunakan M; Unlu I; Vergin C
    Pathol Res Pract; 2006; 202(9):671-7. PubMed ID: 16860492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYCN gene amplification in rhabdomyosarcoma.
    Driman D; Thorner PS; Greenberg ML; Chilton-MacNeill S; Squire J
    Cancer; 1994 Apr; 73(8):2231-7. PubMed ID: 8156531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
    Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
    J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
    Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J
    Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
    Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
    Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS).
    Smith LM; Anderson JR; Coffin CM
    Med Pediatr Oncol; 2002 Jun; 38(6):398-404. PubMed ID: 11984800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of the t(2; 13) and t(1; 13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction.
    Anderson J; Renshaw J; McManus A; Carter R; Mitchell C; Adams S; Pritchard-Jones K
    Am J Pathol; 1997 Feb; 150(2):477-82. PubMed ID: 9033264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.